AI Article Synopsis
- A 44-year-old woman with a history of stage T2N1M0 breast cancer developed dyspnea due to pleural and pericardial effusions, which were confirmed by imaging.
- After draining the fluids, which showed severe abnormality in cytology, her symptoms improved and she was started on weekly paclitaxel treatment.
- The patient responded well, with no recurrence of the effusions, highlighting the effectiveness of systemic chemotherapy after managing the effusions.
Article Abstract
A 44-year-old woman who underwent surgery for left breast cancer 2 years ago presented with dyspnea. Her pathological stage of breast cancer was T2N1M0, ER (3+), PgR (3+), and HER2: 1+. She was treated with tamoxifen only as adjuvant therapy. Pleural effusion in both lungs and pericardial effusion were detected by computed tomography. We aspirated 1,100 mL of the pleural effusion and 700 mL of the pericardial effusion; the cytologies of both were class V. Because her dyspnea disappeared, she was administered weekly paclitaxel. Her pleural effusion and pericardial fluid have not re- emerged. The therapy of choice for pericardial effusion is local chemotherapy or systemic chemotherapy. Systemic chemotherapy after pericardial drainage was effective for this patient. Key words: Breast cancer.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!